TY - JOUR
T1 - Interrelationship between arginine vasotocin, prostaglandin, and uterine contractility in the control of oviposition in the hen (Gallus domesticus)
AU - Saito, Noboru
AU - Shimada, Kiyoshi
AU - Koike, Thomas I.
N1 - Funding Information:
We thank Drs. H. Artman and D. A. Fisher (UCLA, Torrance, CA) for a generous supply of AVT antiserum (R70), Dr. W. H. Sawyer (Columbia University, New York, NY) for bioassaying our AVT standard, and Dr. T. G. Kennedy (University of Western Ontario, London, Canada) for providing us with the PGF, and PGE, antisera. The PGF, and PGE, used as standards were a gift from the Ono Pharmaceutical Co. (Osaka, Japan). The technical assistance of Ms. S. Kinzler and Mr. H. L. Neldon is appreciated. This study was supported by grants-in-aid from the Ministry of Education, Science and Culture of Japan to K. S. (Nos. 60304036, 61560301, and 61304028) and NSF PCM-8316015 to T. I. K.
PY - 1987/9
Y1 - 1987/9
N2 - Uterine electromyographic activity (EMG), plasma concentrations of prostaglandin (PG) F and E, and arginine vasotocin (AVT) were simultaneously measured in relation to PGE2-induced premature oviposition and to indomethacin-blocked oviposition in chickens. The administration of indomethacin (5 mg, im) 3 hr before the predicted time of oviposition delayed egg lay by 8-14 hr, whereas control hens laid eggs at the predicted time. In indomethacin-treated hens increases in uterine EMG activity and plasma concentrations of PGF, PGE, and AVT were not observed at the expected time of oviposition, whereas a marked increase in plasma PGF and AVT occurred during spontaneous oviposition. The intrauterine administration of PGE2 (1 μg) 3 hr before predicted oviposition induced premature egg lay within 5 min. Premature oviposition was accompanied by significant elevations in both uterine EMG activity and plasma levels of AVT. Changes in plasma levels of PGF and PGE were not observed. When premature oviposition was induced, significant increases in EMG activity and plasma concentrations of PGF and AVT were observed at the expected time of oviposition in the absence of an egg in the uterus. The administration of PGE2 at the predicted time of oviposition in hens pretreated with indomethacin induced oviposition which was accompanied by a significant increase in plasma AVT levels. The results suggest that AVT release is stimulated by uterine contractility in chickens.
AB - Uterine electromyographic activity (EMG), plasma concentrations of prostaglandin (PG) F and E, and arginine vasotocin (AVT) were simultaneously measured in relation to PGE2-induced premature oviposition and to indomethacin-blocked oviposition in chickens. The administration of indomethacin (5 mg, im) 3 hr before the predicted time of oviposition delayed egg lay by 8-14 hr, whereas control hens laid eggs at the predicted time. In indomethacin-treated hens increases in uterine EMG activity and plasma concentrations of PGF, PGE, and AVT were not observed at the expected time of oviposition, whereas a marked increase in plasma PGF and AVT occurred during spontaneous oviposition. The intrauterine administration of PGE2 (1 μg) 3 hr before predicted oviposition induced premature egg lay within 5 min. Premature oviposition was accompanied by significant elevations in both uterine EMG activity and plasma levels of AVT. Changes in plasma levels of PGF and PGE were not observed. When premature oviposition was induced, significant increases in EMG activity and plasma concentrations of PGF and AVT were observed at the expected time of oviposition in the absence of an egg in the uterus. The administration of PGE2 at the predicted time of oviposition in hens pretreated with indomethacin induced oviposition which was accompanied by a significant increase in plasma AVT levels. The results suggest that AVT release is stimulated by uterine contractility in chickens.
UR - http://www.scopus.com/inward/record.url?scp=0023404988&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023404988&partnerID=8YFLogxK
U2 - 10.1016/0016-6480(87)90188-2
DO - 10.1016/0016-6480(87)90188-2
M3 - Article
C2 - 3478280
AN - SCOPUS:0023404988
SN - 0016-6480
VL - 67
SP - 342
EP - 347
JO - General and Comparative Endocrinology
JF - General and Comparative Endocrinology
IS - 3
ER -